Gingival enlargement among renal transplant recipients in the era of new-generation immunosuppressants

Journal of Periodontology

Volumn 79, Issue 3, 2008, Pages 453-460

  Greenberg, Katja V ^a,b   Armitage, Gary C ^c,d   Shiboski, Caroline H ^c,d,e  

^a University of California San Francisco ^*

^b Department of Orofacial Sciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Orofacial Sciences   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclosporin; Gingival enlargement; Renal transplant; Tacrolimus

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; FEMALE; GINGIVA OVERGROWTH; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; NONPARAMETRIC TEST; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL; TOOTH PLAQUE;

ADULT; CALCIUM CHANNEL BLOCKERS; CYCLOSPORINE; DENTAL PLAQUE; DRUG INTERACTIONS; FEMALE; GINGIVAL OVERGROWTH; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; QUESTIONNAIRES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TACROLIMUS;

EID: 41449113169     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070434     Document Type: Article

References (39)

1. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
2. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
3. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
4. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
5. Irish W, Sherrill B, Brennan DC, Lowell J, Schnitzler M. Three-year post-transplant graft survival in renaltransplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. Transplantation 2003;76: 1686-1690.
6. Westhoff TH, van der Giet M. Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs 2007;16:1099-1110.
7. van Hooff JP, Christiaans MH, van Duijnhoven EM. Tacrolimus and post-transplant diabetes mellitus in renal transplantation. Transplantation 2005;79:1465-1469.
8. James JA, Jamal S, Hull PS, et al. Tacrolimus is not associated with gingival overgrowth in renal transplant patients. J Clin Periodontol 2001;28:848-852.
9. Bader G, Lejeune S, Messner M. Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus. A case history involving a liver transplant patient. J Periodontol 1998;69:729-732.
10. James JA, Boomer S, Maxwell A, et al. Reduction of gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000; 27:144-148.
11. Hernandez G, Arriba L, Lucas M, de Andres A. Reversion of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol 2000;71:1630-1636.
12. Neuhaus P, Langwehr JM, Williams R. Tacrolimusbased immunosuppression after liver transplantation: A randomized study comparing dual versus triple lowdose regimens. Transpl Int. 1997;10:253-261.
13. Klein H, Palmer CE, Knutson JW. Studies on dental caries I. Dental status and dental needs of elementary school children. Public Health Rep 1938;53:751-765.
14. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
15. Armitage GC. Manual periodontal probing in supportive periodontal therapy. Periodontal 2000 1996;12: 33-39.
16. Aas E. Hyperplasia gingivae diphenylhydantoinae. Acta Odontol Scand 1963;21(Suppl. 34):1-142.
17. Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol 2004;31:126-131.
18. de Oliveira Costa F, Diniz Ferreira S, de Miranda Cota LO, da Costa JE, Aguiar MA. Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens. J Periodontol 2006;77:969-975.
19. Walker R. Reduction of gum enlargement in stable renal allograft cyclosporin recipients converted to tacrolimus (prograf). Nephrology 2002;7:S40.
20. Vescovi P, Meleti M, Manfredi M, Merigo E, Pedrazzi G. Cyclosporin-induced gingival overgrowth: A clinicalepidemiological evaluation of 121 Italian renal transplant recipients. J Periodontol 2005;76:1259-1264.
21. Thomas DW, Baboolal K, Subramanian N, Newcombe R. Cyclosporine A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol 2001;28:706-710.
22. Thomas DW, Newcombe RG, Osboume GR. Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000;69:522-526.
23. Seymour RA, Ellis J, Thomason J. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217-223.
24. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64: 293-297.
25. King GN, Fullinfaw R, Higgins T, Walker R, Francis D, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993;20:286-293.
26. Hassell TM, Hefti A. Drug induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-137.
27. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 1987;14:610-613.
28. Fu E, Nieh S, Chang HL, Wang SL. Dose-dependent gingival overgrowth induced by cyclosporin in rats. J Periodontol 1995;66:594-598.
29. Fuiano G, Pacchiano G, Lotito MA, Vaia E, Matarasso S, Andreucci S. Relations of gingival hypertrophy and blood levels of cyclosporin A in patients with renal transplants. Ann Ital Med Int. 1989;4:161-166.
30. Somacarrera ML, Hernandez G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65: 671-675.
31. Morgan JD, Swarbrick MJ, Edwards CM, Donnelly PK. Cyclosporin, nifedipine and gingival hyperplasia: A randomized controlled study. Transpl Int 1994;7: S320-S321.
32. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
33. Miranda J, Brunet L, Roset P, Berini L, Farre M, Mendieta C. Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil. J Clin Periodontol 2005;32:294-298.
34. Jorgensen MG. Prevalence of amlodipine-related gingival hyperplasia. J Periodontol 1997;68:676-678.
35. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: A communitybased study. J Periodontol 1999;70:63-67.
36. James JA, Marley JJ, Jamal S, et al. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol 2000;27:109-115.
37. Radwan-Oczko M, Boratynska M, Klinger M, Zietek M. Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A. Ann Transplant 2003;8:57-62.
38. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
39. Ingle JI, Howard W, Zwick H. Effects of antihistaminic therapy on diphenylhydantoin (Dilantin) gingival hyperplasia. J Am Dent Assoc 1959;58:65-71.